The No. 1 Trade Show Site in the U.S.

Menu
×
EVENT DATE
Nov 2016
M T W T F S S
282930
EXPO DATE
Nov 2016
M T W T F S S
282930

Venue


Online Event
Location map
Tel:
Type: Online Event

Partners

exhibitus success by design Remington Hotels NorthStar Express Freight

U.S. FDA's Two New Draft Guidances on Device and Software Changes and the 510(k) - By Compliance Global Inc.

B2B

Overview:

Control of medical device changes and a current 510(k) are big issues in recent FDA studies. Companies are held fully responsible for deciding when a new 510(k) filing is warranted. Often this is a difficult decision process. Effective change control and the power of current risk management tools must be a major part of such an analysis.

The U.S. FDA has its current K-97-1 Memorandum and has published two New Draft Guidance Documents, "Deciding When to Submit a 510(k) for a Change to an Existing Device", 1) on the device itself, and 2) on device software, both published on August 08, 2016. These attempt to provide companies tools to perform meaningful, results driven 510(k) / change analysis activities. This is part of a growing push by the Agency to strengthen the 510(k) process.

The addition of simple tools will assist companies in implementing formal, documented, repeatable methods with defensible rationale for their decisions on when a new 510(k) needs submission.

Why Should You Attend:

This webinar will evaluate what the two new draft guidances tell us about current U.S. FDA expectations for analysis and resulting and 510(k) submissions. It will discuss how companies can best document their decisions -- whether or not a new 510(k) filing is warranted.

It will assist in the implementation of formal methods with documented, and defensible rationale; which will also prepare industry for further 510(k) changes in the future. This applies to companies in the Medical Device, device software / firmware development, and combination products fields.

Areas Covered in this Webinar:

Key elements of U.S. FDA’s new Draft Guidance on Deciding When to Submit a 510(k) for a Change to an Existing Device, released August 08, 2016
Key elements of the U.S. FDA’s new Draft Guidance on Deciding When to Submit a 510(k) for a Software Change to an Existing Device, also released August 08, 2016
Impact of proposed guidance documents on current U.S. FDA 510(k) Memorandum K97-1 on Deciding When to Submit a 510(k) for a Change to an Existing Device, in effect since January 10, 1997
How might these drafts affect current device change decisions and 510(k) submissions
What approaches can companies use at present, and the Agency’s expectations

Learning Objectives:

Review of key points of K97-1 / current FDA expectations
Analysis of New Draft Guidance on Deciding When to Submit a 510(k) for a Change to an Existing Device, released August 08, 2016
Analysis of New Draft Guidance on Deciding When to Submit a 510(k) for a Software Change to an Existing Device, also released August 08, 2016
What all this tells companies today/ future

Who Will Benefit:

Senior Management in the Medical Device/ Software Industry
QA Professionals
RA Professionals
R&D Professionals
Engineering Professionals
Software/ Firmware Engineers/ Programmers
Company Change Agents
Document Control Professionals
Production Personnel
Operations Personnel
Consultants

Speaker Profile:

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years' experience in U.S. FDA regulated industries, 19 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).

For more detail please click on this below link:

https://www.complianceglobal.us/product/700614

Email: referrals@complianceglobal.us
Toll Free: +1-844-746-4244
Tel: +1-516-900-5515

Fax: +1-516-900-5510

Don't wait to register for the U.S. FDA's Two New Draft Guidances on Device and Software Changes and the 510(k) - By Compliance Global Inc.. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.

EVENT CONTACTS


Compliance Global Inc
2754 80th Avenue
New Hyde Park, NY 11040
(516) 900-5515

Compliance Global Inc
(516) 900-5515

EVENT DETAILS

Primary Industry:
Medical Technology
Other Industries:
Manufacturing, Medical, Medical Technology, Professional Healthcare
Audience:
Senior Management in the Medical Device/ Software Industry
QA Professionals
RA Professionals
R&D Professionals
Engineering Professionals
Software/ Firmware Engineers/ Programmers
Company Change Agents
Document Control Professionals
Production Personnel
Operations Personnel
Consultants
Notes:
Attendee Statistics:
Show Owner:
Compliance Global Inc.
Sponsorship: Yes

Exhibitor Information +

Booth Details:

Booth Size
Booth Cost
No Exhibiting
Amenities
Electricity:
n/a
Water:
n/a
Generator:
n/a
Marketing Vehicles Allowed:
n/a
Services
n/a

floor plan

exhibitor list

MORE events +

BUSINESS+
HEALTH CARE+
MANUFACTURING+
TECHNOLOGY+
2017: 2,575 Trade Shows
2018: 575 Trade Shows
© copyright since 2008 All Rights Reserved eventsinamerica.com
378
page views